Sweden
· Delayed Price · Currency is SEK SynAct Pharma AB Statistics
Total Valuation
STO:SYNACT has a market cap or net worth of SEK 874.81 million. The enterprise value is 815.48 million.
| Market Cap | 874.81M |
| Enterprise Value | 815.48M |
Important Dates
The last earnings date was Tuesday, February 18, 2025.
| Earnings Date | Feb 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:SYNACT has 49.01 million shares outstanding. The number of shares has increased by 21.55% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 49.01M |
| Shares Change (YoY) | +21.55% |
| Shares Change (QoQ) | +1.09% |
| Owned by Insiders (%) | 18.08% |
| Owned by Institutions (%) | 14.10% |
| Float | 23.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.87 |
| P/TBV Ratio | 14.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.90 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.30 |
| Quick Ratio | 2.66 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -106.36 |
Financial Efficiency
Return on equity (ROE) is -42.22% and return on invested capital (ROIC) is -28.63%.
| Return on Equity (ROE) | -42.22% |
| Return on Assets (ROA) | -22.56% |
| Return on Invested Capital (ROIC) | -28.63% |
| Return on Capital Employed (ROCE) | -37.17% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -13.73M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +115.32% in the last 52 weeks. The beta is 0.98, so STO:SYNACT's price volatility has been similar to the market average.
| Beta (5Y) | 0.98 |
| 52-Week Price Change | +115.32% |
| 50-Day Moving Average | 12.27 |
| 200-Day Moving Average | 9.39 |
| Relative Strength Index (RSI) | 72.68 |
| Average Volume (20 Days) | 265,890 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -89.98M |
| Pretax Income | -90.83M |
| Net Income | -82.40M |
| EBITDA | -15.40M |
| EBIT | -89.98M |
| Earnings Per Share (EPS) | -2.08 |
Balance Sheet
The company has 61.21 million in cash and 1.88 million in debt, giving a net cash position of 59.33 million or 1.21 per share.
| Cash & Cash Equivalents | 61.21M |
| Total Debt | 1.88M |
| Net Cash | 59.33M |
| Net Cash Per Share | 1.21 |
| Equity (Book Value) | 214.17M |
| Book Value Per Share | 4.61 |
| Working Capital | 65.54M |
Cash Flow
| Operating Cash Flow | -89.20M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:SYNACT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.55% |
| Shareholder Yield | -21.55% |
| Earnings Yield | -9.42% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |